Zobrazeno 1 - 10
of 109
pro vyhledávání: '"radiopharmaceutical agent"'
Autor:
André Damasceno, Martha Sahylí Ortega Pijeira, Eduardo Ricci-Junior, Luciana Magalhães Rebelo Alencar, Derya İlem-Özdemir, Ralph Santos-Oliveira
Radiopharmaceuticals are radioactive drugs, with a very short shelf life, in most of the cases. The number of proceedings using radiopharmaceuticals increases each day worldwide and for many countries the price of radiopharmaceuticals can represent a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::398324502c2e4920ff0699209176d7f8
https://hdl.handle.net/11454/79569
https://hdl.handle.net/11454/79569
Infection is one of the important burdens on the health care system, not only due to leading morbidity and mortality but also because of the development of antibiotic resistance. Although the infection can be diagnosed by imaging techniques, more eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42c52240c07e48f300f153bd505ccb0d
https://hdl.handle.net/11454/79877
https://hdl.handle.net/11454/79877
Autor:
Ozge Kilicoglu, Nayim Sepay, Emre Ozgenc, Evren Gundogdu, Umit Kara, Sultan Alomairy, M.S. Al-Buriahi
Publikováno v:
Applied Radiation and Isotopes. 191:110553
Fluorodeoxyglucose (FDG), marked with the most used Positron Emission Tomography (PET) radiopharmaceutical Fluorine-18 (F-18), is a glucose analog and is taken to living cells through membrane glucose carriers. F-18 FDG involvement in tissue is propo
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
(IJRE) International Journal of Research and Ethics (ISSN 2665-7481). 3
The treatment of hyperthyroidism with iodine-131 has been recognized on nuclear medicine as simple, effective and inexpensive, this kind of radiopharmaceutical is chosen by the majority of medical centers by administering a minimum effective dose ena
Autor:
Maria Gule-Monroe, William Row, Edgar G. Ordóñez-Rubiano, Jeffrey S. Weinberg, Claudio E. Tatsui, Jason M. Johnson, Diego F. Solano-Noguera
Publikováno v:
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Study Design.A case series of dual time-point 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (18F-FDG PET/CT) for the diagnosis of spinal cord sarcoidosis.Objective.The aim of this study was to illustrate three cases of
Autor:
Laura Evangelista, Lea Cuppari
Publikováno v:
Atlas of Clinical PET-CT in Treatment Response Evaluation in Oncology ISBN: 9783030688578
Quantification of tumor burden by medical imaging is often used in our daily clinical practice to assess the effectiveness of various anticancer therapies in soft-tissue tumors. Computed tomography (CT) represents the most common technique employed f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cae5722c2974fd9acd22f660fbdd8102
https://doi.org/10.1007/978-3-030-68858-5_10
https://doi.org/10.1007/978-3-030-68858-5_10
Autor:
Muhammet Arslan, Olga Yaylali, Doğangün Yüksel, Halil Serdar Aslan, Fatma Ezgi Can, Fikri Selcuk Simsek, Erhan Ugurlu, Emel Kılıçarslan, Ferda Bir
Purpose: Sometimes, characterization of pleural effusion (PE) can be challenging especially in patients whom invasive procedures/recurrent invasive procedures cannot be performed. The main purpose of the study is to answer this question, Can 18F-FDG-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::353c493c1b977185a981b45cc32c1af0
https://hdl.handle.net/11499/47388
https://hdl.handle.net/11499/47388
Autor:
Mark D. Hurwitz, Ann E. Donnelly
Publikováno v:
Chemotherapy and Immunotherapy in Urologic Oncology ISBN: 9783030520205
A high percentage of patients with metastatic prostate cancer have evidence of bone metastases that are either symptomatic or visible on radiographic imaging (Roodman, N Engl J Med 350:1655–1664, 2004). Patients with osteoblastic metastatic disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2905528e420b15f124aa7b83bf63e644
https://doi.org/10.1007/978-3-030-52021-2_10
https://doi.org/10.1007/978-3-030-52021-2_10
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncology, Vol 10 (2020)
The evaluation of antibody-targeted or peptide-targeted radiopharmaceuticals as monotherapy or in oncological drug combinations requires programmatic collaboration within the National Cancer Institute (NCI) clinical trial enterprise. Phase 0 trials p